Metronomic Chemotherapy for Metastatic Breast Cancer - a Systematic Review of the Literature.
Ontology highlight
ABSTRACT: Conventional chemotherapy is generally administered in high doses followed by a treatment-free period to give the body needful time to recover. This "maximum tolerated dose" approach results in high response rates. However, long periods between therapy cycles can lead to development of resistance mechanisms and consequently disease progression. One of the most interesting alternative strategies is metronomic chemotherapy. This concept relies on the continuous administration of chemotherapy at low doses and aims at targeting endothelial cells in the tumor bed as well. Recently, metronomic chemotherapy has been incorporated into the recommendations issued by the German AGO expert panel (www.ago-online.de). A systematic review of PubMed/Medline, ClinicalTrials.gov, the European Clinical Trial
SUBMITTER: Banys-Paluchowski M
PROVIDER: S-EPMC4873299 | biostudies-literature | 2016 May
REPOSITORIES: biostudies-literature
ACCESS DATA